Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001731122-25-000609
Filing Date
2025-04-25
Accepted
2025-04-25 16:35:45
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A e6535_defa14a.htm DEFA14A 7558
2 GRAPHIC p_001.jpg GRAPHIC 783751
3 GRAPHIC p_002.jpg GRAPHIC 438834
  Complete submission text file 0001731122-25-000609.txt   1692679
Mailing Address 630 5TH AVENUE 20TH FLOOR NEW YORK NY 10111
Business Address 630 5TH AVENUE 20TH FLOOR NEW YORK NY 10111 844-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

EIN.: 980608404 | Fiscal Year End: 0930
Type: DEFA14A | Act: 34 | File No.: 001-37606 | Film No.: 25874733
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)